Projekt

Protocol Title: A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)

Abgeschlossen - Rekrutierung – beendet · 2020 bis 2024

Fischer Stefanie, Hutter Franziska, Quinter Janine